The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Videos

John Bertagnolli, vice-president of Commercial Operations at Selkirk Pharma, discusses considerations when building and scaling up pharmaceutical facilities, including contamination control and aseptic processing challenges.

Considerations in Pharmaceutical Facility Design (CPHI North America 2024)

Feliza Mirasol is the science editor for 

Articles

Ecolab Life Sciences and Repligen have launched a new affinity resin, DurA Cycle, for large-scale biologics manufacturing.

New Affinity Resin Launched by Ecolab Life Sciences and Repligen for Biologics Manufacturing

Krizia M. Karry, PhD, ishead of Global Technical Marketing, Pharma Solutions, BASF.

Brian Carlin is president and owner of Carlin Pharma Consulting LLC.

Nigel Langley, PhD, MBA, is global technical director at Gaylord Life Sciences and Immediate Past Chair, IPEC- Americas.

R. Christian Moreton, PhD, is vice-president of pharmaceutical sciences at Finnbrit Consulting and a member of Pharmaceutical Technology’s editorial advisory board.

David Schoneker is president, Black Diamond Regulatory Consulting, LLC

Katherine L. Ulman is president of KLU Consulting.

Joseph Zeleznik is technical product director, IMCD US

Key information is needed for excipients and their potential impact on continuous manufacturing processes.

Understanding Excipient Characteristics to Ensure Robust Continuous Manufacturing 

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Leveraging automation advancements can help improve efficiency in aseptic processing and speed up commercialization of critical drug products. 

Streamlining Aseptic Processes through Automation 

Syngene's new production platform offers rapid protein synthesis with lower risk.

New Syngene Platform Aims for Rapid Protein Production

The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.

AGC Biologics Completes Denmark Expansion to Double Single-Use Bioreactor Capacity

Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.

Syntegon Acquires Telstar

USP and FDA publish reports detailing drug shortage numbers and challenges through 2023.

Drug Shortage Reports Emphasize Continuing Problems

The biopharma industry is looking at continuous chromatography for sensitive molecules.

Evaluating the Use of Continuous Chromatography

The final drug product relies on the quality and reliability of the raw materials used in its production.

Diversifying the Supply of Raw Materials 

Aseptic/Sterile Processing

Cleanroom Equipment and Supplies

Clinical Trial Materials